Abstract
Next-Generation Sequencing (NGS) is an advanced technology that enables quick and precise analyzes of DNA and RNA sequences. The use of the Illumina MiniSeq NGS platform (Illumina, USA) for sequencing the SARS-CoV-2 coronavirus genome allows for accurate identification of the virus, analysis of its genetic variants and monitoring of its evolution. It is a valuable tool supporting epidemiological research, developing effective strategies to combat the virus and better understanding the COVID-19 disease it causes.Molecular surveillance of the genetic variability of the SARS-CoV-2 virus using this technology has been carried out at the Interdisciplinary Molecular Research Laboratory at the Provincial Sanitary and Epidemiological Station in Katowice since September 2021. NGS sequencing is used to identify and track new variants and subvariants of the SARS-CoV-2 virus in the Silesian, Lesser Poland and Opole Voivodeships. During research at the WSSE laboratory in Katowice, many SARS-CoV-2 variants with different levels of infectivity and consequences for public health were documented, i.e. Alpha (B.1.1.7), Gamma (P.1), Delta (B.1.617. 2) or Omicron (B.1.1.529).

This publication has 36 references indexed in Scilit: